Aldeyra Therapeutics, Inc.
ALDX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001341235
No open-market purchases or sales by Aldeyra Therapeutics, Inc. insiders were filed in the last 90 days; 107 institutions reported holding it in 13F filings for Q2 2026, worth $77.7M in total; no superinvestor holds it.
Q3 2025 vs. Q2 2025
How the institutions holding Aldeyra Therapeutics, Inc. changed between Q2 2025 and Q3 2025.
All holders in Q3 2025All holders in Q2 2025
| Measure | Q2 2025 | Q3 2025 | Change |
|---|---|---|---|
| Holders | 122 | 131 | +9 |
| Shares | 34.1M | 39.1M | +5.00M (+14.7%) |
| Value | $130.8M | $204.2M | +$73.4M (+56.2%) |
New holders (24)
Institutions that held Aldeyra Therapeutics, Inc. at the end of Q3 2025 but not at the end of Q2 2025.
Sold out (15)
Institutions that held Aldeyra Therapeutics, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.
| Institution | Shares, Q2 2025 | Value, Q2 2025 |
|---|---|---|
| ADAR1 Capital Management, LLC | 249,920 | $957.2K |
| Walleye Capital LLC | 155,609 | $596.0K |
| Panagora Asset Management Inc | 72,059 | $276.0K |
| Kennondale Capital Management LLC | 56,729 | $217.3K |
| Los Angeles Capital Management LLC | 16,320 | $62.5K |
| Corton Capital Inc. | 14,940 | $57.2K |
| Caption Management, LLC | 12,664 | $48.5K |
| ProShare Advisors LLC | 11,127 | $42.6K |
| Two Sigma Securities, LLC | 11,002 | $42.1K |
| Inspirion Wealth Advisors, LLC | 10,000 | $38.3K |
| Raymond James Financial Inc | 2,998 | $11.5K |
| Kozak & Associates, Inc. | 1,000 | $4.52K |
| Stephens Consulting, LLC | 1,000 | $3.83K |
| Caitong International Asset Management Co., Ltd | 430 | $1.65K |
| Skopos Labs, Inc. | 51 | $196 |